Cargando…
Response to low-dose intravenous immunoglobulin in a case of recalcitrant Darier disease
Autores principales: | Legrand, Adeline, Darrigade, Anne-Sophie, Taieb, Alain, Milpied, Brigitte, Seneschal, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033304/ https://www.ncbi.nlm.nih.gov/pubmed/32149174 http://dx.doi.org/10.1016/j.jdcr.2020.01.007 |
Ejemplares similares
-
Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study
por: DUPONT, Aurore, et al.
Publicado: (2023) -
Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!
por: Luherne, Camille, et al.
Publicado: (2019) -
Long-term improvement of recalcitrant Darier disease with photon and electron beam radiation therapy
por: Leung, Nicole, et al.
Publicado: (2018) -
Recalcitrant, delayed pressure urticaria treated with long-term intravenous immunoglobulin
por: Soliman, Yssra S., et al.
Publicado: (2020) -
Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses
por: SCARPONE, Roberta, et al.
Publicado: (2020)